Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | AKT1 | P31749 | 1/20 | 0.33 |
| ▸ | TLR2 | O60603 | 1/20 | 0.32 |
| ▸ | TACR2 | P21452 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17841867 | 0.85 | MEN1 (0.40) | MEN1KMT2AAKT1TLR2TACR2 | |
| SCHEMBL20591089 | 0.76 | CA12 (0.33) | CA2 | |
| SCHEMBL20677260 | 0.72 | MGLL (0.40) | SMN1; SMN2CA2 | |
| SCHEMBL21408701 | 0.69 | MEN1 (0.47) | MEN1KMT2ASMN1; SMN2PTGER3CA2 | |
| SCHEMBL20677174 | 0.68 | KIF11 (0.36) | MEN1KMT2ATLR2TACR2CA2 | |
| SCHEMBL20677208 | 0.67 | HTT (0.47) | SMN1; SMN2CA2 | |
| SCHEMBL28503407 | 0.67 | MAOA (0.48) | MEN1KMT2ACA2 | |
| SCHEMBL19493077 | 0.66 | MGLL (0.69) | SMN1; SMN2CA2 | |
| SCHEMBL28547221 | 0.66 | MGLL (0.69) | SMN1; SMN2CA2 | |
| SCHEMBL28894450 | 0.66 | MGLL (0.43) | SMN1; SMN2CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4406606-A2 | ANTIBODY DRUG CONJUGATES (ADCS) AND ANTIBODY PRODRUG CONJUGATES (APDCS) WITH ENZYMATICALLY CLEAVABLE G | Bayer Pharma Aktiengesellschaft (DE) | 2024-07-31 | — | — | EP | disclosed |